首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.
【2h】

Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.

机译:鉴定低分子量磷脂酶A2的特定区域(残基21-40)作为这些酶抑制剂的基于结构设计的潜在目标。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have identified a specific region of porcine pancreatic phospholipase A2 (residues 21-40) which interacts with a neutralizing antibody causing a dramatic inhibition of its enzymatic activity (Ki in the order of 10(-8) M). The binding equilibrium of the antibody-phospholipase A2 complex is reached in < 3 min at 37 degrees C. Fab fragments are equally effective phospholipase A2 inhibitors, as are intact IgG molecules. The inhibition is virtually complete and noncompetitive with respect to phosphatidylcholine substrate. The formation of precipitating immunocomplexes is not involved in the inhibition. The region of phospholipase A2 (residues 21-40) recognized by this antibody includes a highly conserved sequence which contains several functionally important residues of both group I and group II phospholipases A2. These data suggest that amino acid residues in this region of porcine pancreatic phospholipase A2 are accessible for interaction with inhibitors such as neutralizing antibodies and that agents specifically interacting with this region may have potent phospholipase A2 inhibitory activity. Thus, this conserved region of low molecular weight, extracellular phospholipases A2 is a potential target for structure-based design of specific noncompetitive inhibitors of these enzymes. Since these extracellular phospholipases A2 are suggested to play a pathogenic role in several important human diseases, the development of such pharmacologic inhibitors is of potential clinical importance.
机译:我们已经鉴定出猪胰腺磷脂酶A2的特定区域(残基21-40),该区域与中和抗体相互作用,引起其酶活性的显着抑制(Ki为10(-8)M)。抗体-磷脂酶A2复合物的结合平衡是在37°C下于3分钟之内达到的。Fab片段与完整的IgG分子一样是等效的磷脂酶A2抑制剂。对于磷脂酰胆碱底物,抑制作用实际上是完全的并且是非竞争性的。沉淀的免疫复合物的形成不参与抑制。该抗体识别的磷脂酶A2区域(21-40位残基)包括一个高度保守的序列,该序列包含I类和II类磷脂酶A2的几个功能上重要的残基。这些数据表明,猪胰磷脂酶A2该区域中的氨基酸残基可与抑制剂如中和抗体相互作用,并且与该区域特异性相互作用的试剂可能具有有效的磷脂酶A2抑制活性。因此,该保守的低分子量胞外磷脂酶A2区域是这些酶的特定非竞争性抑制剂基于结构的设计的潜在目标。由于建议这些细胞外磷脂酶A2在几种重要的人类疾病中起致病作用,因此开发这种药理抑制剂具有潜在的临床重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号